These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34711516)

  • 1. Mild COVID-19 infection does not alter the ovarian reserve in women treated with ART.
    Kolanska K; Hours A; Jonquière L; Mathieu d'Argent E; Dabi Y; Dupont C; Touboul C; Antoine JM; Chabbert-Buffet N; Daraï E
    Reprod Biomed Online; 2021 Dec; 43(6):1117-1121. PubMed ID: 34711516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization.
    Reijnders IF; Nelen WL; IntHout J; van Herwaarden AE; Braat DD; Fleischer K
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():45-50. PubMed ID: 26967346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of age and antimullerian hormone in assisted reproductive technology program outcome.
    Himabindu Y; Gopinathan KK; Pandey AK; Sriharibabu M
    Indian J Physiol Pharmacol; 2013; 57(1):9-15. PubMed ID: 24020093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF/ICSI cycle.
    Lin PY; Huang FJ; Kung FT; Chiang HJ; Lin YJ; Lin YC; Lan KC
    Int J Clin Exp Pathol; 2014; 7(9):6245-53. PubMed ID: 25337276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the localisation of endometriosis lesions on ovarian reserve and assisted reproduction techniques outcomes.
    Ashrafi M; Arabipoor A; Hemat M; Salman-Yazdi R
    J Obstet Gynaecol; 2019 Jan; 39(1):91-97. PubMed ID: 30257599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the likely IVF/ICSI outcomes if there is a discrepancy between serum AMH and FSH levels? A multicenter retrospective study.
    Daney de Marcillac F; Pinton A; Guillaume A; Sagot P; Pirrello O; Rongieres C
    J Gynecol Obstet Hum Reprod; 2017 Oct; 46(8):629-635. PubMed ID: 28843783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of serum Anti-Mullerian Hormone levels on the results of assisted reproductive technologies. Single-center retrospective study from 2011 cycles (ICSI and bilateral tubal obstruction excluded)].
    Dosso N; Robin G; Catteau-Jonard S; Pigny P; Leroy-Billiard M; Dewailly D
    J Gynecol Obstet Biol Reprod (Paris); 2015 Jan; 44(1):63-71. PubMed ID: 24951378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of SARS-CoV-2 mRNA vaccination on AMH concentrations in infertile women.
    Horowitz E; Mizrachi Y; Ganer Herman H; Oz Marcuschamer E; Shalev A; Farhi J; Barber E; Orna SH; Raziel A; Weissman A
    Reprod Biomed Online; 2022 Oct; 45(4):779-784. PubMed ID: 35985956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does an association exist between menstrual cycle length within the normal range and ovarian reserve biomarkers during the reproductive years? A systematic review and meta-analysis.
    Younis JS; Iskander R; Fauser BCJM; Izhaki I
    Hum Reprod Update; 2020 Nov; 26(6):904-928. PubMed ID: 32514566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment.
    Peuranpää P; Hautamäki H; Halttunen-Nieminen M; Hydén-Granskog C; Tiitinen A
    Hum Reprod; 2020 Mar; 35(3):504-515. PubMed ID: 32219343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve.
    Oriol B; Barrio A; Pacheco A; Serna J; Zuzuarregui JL; Garcia-Velasco JA
    Fertil Steril; 2008 Nov; 90(5):1579-82. PubMed ID: 18054933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Ovarian Reserve Screening with Anti-Müllerian Hormone for Reproductive Age Women Deferring Pregnancy.
    Grossman LC; Safier LZ; Kline MD; Chan CW; Lobo RA; Sauer MV; Douglas NC
    J Womens Health (Larchmt); 2017 Apr; 26(4):345-351. PubMed ID: 27906603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone dynamics during GNRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Apr; 69(2):128-134. PubMed ID: 27310675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle].
    Zhang XR; Ding LL; Tang R; Sheng Y; Qin YY; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):180-5. PubMed ID: 27030496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
    Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of repetitive oocyte retrieval on the ovarian reserve: a retrospective cohort study.
    Marschalek J; Ott J; Aitzetmueller M; Mayrhofer D; Weghofer A; Nouri K; Walch K
    Arch Gynecol Obstet; 2019 May; 299(5):1495-1500. PubMed ID: 30790103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation.
    Liebenthron J; Reinsberg J; van der Ven K; Saenger N; Kruessel JS; von Wolff M
    Hum Reprod; 2019 Dec; 34(12):2513-2522. PubMed ID: 31782794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling.
    Pilsgaard F; Grynnerup AG; Løssl K; Bungum L; Pinborg A
    Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1105-1113. PubMed ID: 29476703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMH Highly Correlates With Cumulative Live Birth Rate in Women with Diminished Ovarian Reserve Independent of Age.
    Tal R; Seifer DB; Tal R; Granger E; Wantman E; Tal O
    J Clin Endocrinol Metab; 2021 Aug; 106(9):2754-2766. PubMed ID: 33729496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.